Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study

被引:0
|
作者
Gladman, Dafna [1 ]
Coates, Laura [2 ]
Mease, Philip [3 ,4 ]
van den Bosch, Filip [5 ]
Rychlewska-Hanczewska, Anna [6 ]
Tasset, Chantal [7 ]
Meuleners, Luc [7 ]
Trivedi, Mona [8 ]
Guo, Ying [8 ]
Besuyen, Robin [7 ]
Helliwell, Philip [9 ]
机构
[1] Univ Toronto, Krembil Res Inst, Dept Med, Toronto Western Hosp, Toronto, ON, Canada
[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
[3] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA
[4] Univ Washington, Sch Med, Seattle, WA USA
[5] Ghent Univ Hosp, Ghent, Belgium
[6] AI Ctr Med, Poznan, Poland
[7] Galapagos NV, Mechelen, Belgium
[8] Gilead Sci USA, Foster City, CA USA
[9] Univ Leeds, Leeds, W Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
70
引用
收藏
页码:1066 / 1067
页数:2
相关论文
共 50 条
  • [11] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [12] A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome
    Garcia-Borreguero, Diego
    Grunstein, Ronald
    Sridhar, Guruswamy
    Dreykluft, Tilman
    Montagna, Pasquale
    Dom, Rene
    Lainey, Eric
    Moorat, Anne
    Roberts, James
    [J]. SLEEP MEDICINE, 2007, 8 (7-8) : 742 - 752
  • [13] Long-term safety and effectiveness of brexpiprazole in Japanese patients with schizophrenia: A 52-week, open-label study
    Ishigooka, Jun
    Iwashita, Shuichi
    Tadori, Yoshihiro
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (06) : 445 - 453
  • [14] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Nash, Peter
    Coates, Laura C.
    Kivitz, Alan
    Mease, Philip J.
    Gladman, Dafna D.
    Covarrubias-Cobos, Jose A.
    Fitzgerald, Oliver
    Fleishaker, Dona
    Wang, Cunshan
    Wu, Joseph
    Hsu, Ming-Ann
    Menon, Sujatha
    Fallon, Lara
    Romero, Ana Belen
    Kanik, Keith S.
    [J]. RHEUMATOLOGY AND THERAPY, 2020, 7 (03) : 553 - 580
  • [15] Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
    Peter Nash
    Laura C. Coates
    Alan J. Kivitz
    Philip J. Mease
    Dafna D. Gladman
    José A. Covarrubias-Cobos
    Oliver FitzGerald
    Dona Fleishaker
    Cunshan Wang
    Joseph Wu
    Ming-Ann Hsu
    Sujatha Menon
    Lara Fallon
    Ana Belén Romero
    Keith S. Kanik
    [J]. Rheumatology and Therapy, 2020, 7 : 553 - 580
  • [16] LONG-TERM EFFICACY OF THE ORAL SELECTIVE JANUS KINASE 1 INHIBITOR FILGOTINIB IN PSORIATIC ARTHRITIS: WEEK 52 RESPONSE PATTERNS IN INDIVIDUAL PATIENTS FROM AN OPEN-LABEL EXTENSION (OLE) STUDY (EQUATOR2)
    Gladman, D. D.
    Coates, L. C.
    Van den Bosch, F.
    Helliwell, P.
    Tasset, C.
    Meuleners, L.
    Gilles, L.
    Gheyle, L.
    Trivedi, M.
    Alani, M.
    Besuyen, R.
    Mease, P. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 759 - 759
  • [17] Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study
    Ikeda, Manabu
    Mori, Etsuro
    Kosaka, Kenji
    Iseki, Eizo
    Hashimoto, Mamoru
    Matsukawa, Noriyuki
    Matsuo, Kazutaka
    Nakagawa, Masaki
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 36 (3-4) : 229 - 241
  • [18] Long-term efficacy and safety of aripiprazole vs. olanzapine in schizophrenia:: a 52-week, open-label extension study
    Ebrecht, M
    Modell, S
    Werner, C
    Spevakné-Göröcs, T
    Kungel, M
    [J]. PHARMACOPSYCHIATRY, 2005, 38 (05) : 238 - 238
  • [19] Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial.
    Becker, Michael A.
    Baraf, Herbert S. B.
    Yood, Robert A.
    Dillon, Aileen M.
    Vazquez-Mellado, Janitzia
    Ottery, Faith D.
    Khanna, Dinesh
    Sundy, John S.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S69 - S70
  • [20] Long-term Outcomes with Filgotinib, an Oral Selective Janus Kinase 1 Inhibitor: 100-week Data from an Open-label Extension (OLE) Study in Patients with Active Psoriatic Arthritis (PsA)
    Coates, Laura
    Gladman, Dafna
    Van den Bosch, Filip
    Helliwell, Philip
    Rychlewska-Hanczewska, Anna
    Stanislavchuk, Mykola
    Gilles, Leen
    Gheyle, Lien
    Liu, Ke
    Trivedi, Mona
    Alani, Muhsen
    Besuyen, Robin
    Mease, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72